The initiatives to improve healthcare access — including Ayushman Bharat, which provides financial protection and better ...

GlaxoSmithKline (GSK) has accelerated the review of its Horlicks business in India, hoping to sell it for over $4 billion and potentially use the cash for Novartis' buy out deal. Bloomberg ...

Augmentin, a combination of amoxicillin and clavulanate potassium, maintained its top-selling brand status in the Indian pharmaceutical market, selling around Rs 75-80 crore per month. The strong ...

Carson Dalton started his new position as Executive Vice President - Communications & Government Affairs at GSK, a British ...

Mumbai: GlaxoSmithKline Pharmaceuticals Limited has announced the appointment of Carson Dalton as Executive Vice President, ...

(Reuters) - India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin. The Indian ...

In the past, Sudeep has worked on campaigns for brands like Mercedes-Benz India, Taj Hotels, Volini, Royal Enfield, J&J, GSK ...

India's GlaxoSmithKline Pharma reports higher profit on strong demand for respiratory drugs India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday ...

32 per equity share for the year. This dividend for the year ended 31 March 2024 is subject to the approval of Members at the Annual General Meeting on 28 June 2024 and will be paid on or after 1 ...

GlaxoSmithKline (GSK) has accelerated the review of its Horlicks business in India, hoping to sell it for over $4 billion and potentially use the cash for Novartis' buy out deal. Bloomberg ...